{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:53:40Z","timestamp":1791366820456,"version":"4.3.1"},"reference-count":61,"publisher":"Bentham Science Publishers Ltd.","issue":"26","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Prostate cancer is the fourth most commonly diagnosed cancer\nworldwide and the eighth leading cause of cancer-related mortality, primarily affecting\nelderly males. Conventional therapeutic approaches, while effective in some cases, often\ncome with substantial side effects, posing particular challenges for older patients. As a\nresult, the exploration of natural compounds from traditional Chinese medicine (TCM)\nas potential anticancer agents has gained increasing attention. Sesamin, a dietary lignan\nfound in sesame seeds and frequently used in TCM, has shown promise in preliminary\nstudies for its antioxidant, anti-inflammatory, and potential anticancer properties. However,\nits specific effects and underlying mechanisms against prostate cancer cells remain\ninadequately characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This study investigated the anticancer effects of sesamin on human\nprostate cancer DU145 cells. Cell viability was evaluated using MTT assays. Apoptosis\ninduction and cell cycle distribution were assessed by flow cytometry. Protein expression\nlevels of PPAR-\u03b3, p21, and p53 were measured using Western blotting. Additionally,\nin silico molecular docking was performed using the LibDock algorithm to evaluate\nsesamin\u2019s binding affinity with the target proteins PPAR-\u03b3 and p21.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Sesamin treatment significantly reduced the viability of DU145 cells in a dosedependent\nmanner. Flow cytometry revealed increased apoptosis and cell cycle arrest at\nthe G1 phase. Western blot analysis showed upregulated expression of PPAR-\u03b3 and p21,\nwhile p53 expression remained largely unchanged. Molecular docking analysis demonstrated\nstrong binding affinity of sesamin to PPAR-\u03b3 (LibDock score: 125.03) and p21\n(LibDock score: 105.45), supporting its involvement in a p53-independent apoptotic\nmechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The study demonstrates that sesamin exerts significant anticancer effects on\nprostate cancer DU145 cells by inhibiting cell viability, inducing apoptosis, and causing\nG1 phase cell cycle arrest. The upregulation of PPAR-\u03b3 and p21, coupled with\nunchanged p53 expression, suggests that sesamin may activate a p53-independent pathway,\na valuable feature in treating prostate cancers with defective p53 signaling. Molecular\ndocking results corroborate these findings, indicating direct interactions between sesamin\nand its molecular targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Sesamin exhibits promising antiproliferative and pro-apoptotic activities\nagainst DU145 prostate cancer cells. Its potential to act as a G1-phase-specific chemotherapeutic\nagent via a p53-independent mechanism warrants further investigation\nand development as a natural candidate for prostate cancer therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673401248251028114820","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:22:53Z","timestamp":1769145773000},"page":"5521-5539","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational Analysis and in vitro Validation of the Anti-Prostate Cancer Activity of Sesamin from Sesamum indicum"],"prefix":"10.2174","volume":"33","author":[{"given":"Shu-Ming","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Nutrition, Hungkuang University, Taichung City 433, Taiwan"},{"name":"Department of Clinical Nutrition, Nantou Hospital, Ministry of Health and Welfare, Nantou City, 540, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hung","family":"Chuang","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Hungkuang University, Taichung City 433, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marineil C.","family":"Gomez","sequence":"additional","affiliation":[{"name":"Biological Engineering Cluster, School of Chemical, Biological and Materials Engineering and Sciences, Map\u00faa University, Manila, 1002, Philippines"},{"name":"Department of Biology, School of Health Sciences, Map\u00faa University, Makati 1200, Philippines"},{"name":"School of Graduate Studies, Map\u00faa University, Manila, 1002, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemmuel L.","family":"Tayo","sequence":"additional","affiliation":[{"name":"Department of Biology, School of Health Sciences, Map\u00faa University, Makati 1200, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yang","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Chemical and Materials Engineering, National I-Lan University, Yilan, 260, Taiwan"},{"name":"Department of Food Science, National Taiwan Ocean University, Keelung, 202, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Wei","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Food Science, National Taiwan Ocean University, Keelung, 202, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chang","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nantou Hospital, Ministry of Health and Welfare, Nantou City, 540, Taiwan"},{"name":"Department of Healthcare Administration, Central Taiwan University of Science and Technology, Taichung, 406, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"Ferlay J.","year":"2021","unstructured":"Ferlay J.; Colombet M.; Soerjomataram I.; Parkin D.M.; Pi\u00f1eros M.; Znaor A.; Bray F.; Cancer statistics for the year 2020: An overview. Int J Cancer  2021,149(4),778-789","journal-title":"Int J Cancer"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H.","year":"2021","unstructured":"Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2021,71(3),209-249","journal-title":"CA Cancer J Clin"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"22336","DOI":"10.1097\/MD.0000000000022336","volume":"99","author":"Lin P.H.","year":"2020","unstructured":"Lin P.H.; Chang S.W.; Tsai L.H.; Kan H.C.; Liu J.M.; Chuang C.K.; Pang S.T.; Yu K.J.; Increasing incidence of prostate cancer in Taiwan. Medicine  2020,99(39),22336","journal-title":"Medicine"},{"key":"ref=4","year":"2022","unstructured":"Incidence and mortality rates for the top 10 cancer in Taiwan.  Available from:  https:\/\/twcr.tw\/wp-content\/uploads\/2024\/02\/Top-10-cancers-in-Taiwan-2021.pdf2022"},{"key":"ref=5","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.94040","author":"Mohan L.","year":"2021","unstructured":"Mohan L.; Plant-based drugs as an adjuvant to cancer chemotherapy. Alternative Medicine Update  2021","journal-title":"Alternative Medicine Update"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.5681\/apb.2014.062","volume":"4","author":"Safarzadeh E.","year":"2014","unstructured":"Safarzadeh E.; Shotorbani S.S.; Baradaran B.; Herbal medicine as inducers of apoptosis in cancer treatment. Adv Pharm Bull  2014,4(Suppl 1),421-427","journal-title":"Adv Pharm Bull"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fphar.2019.01614","volume":"10","author":"Choudhari A.S.","year":"2020","unstructured":"Choudhari A.S.; Mandave P.C.; Deshpande M.; Ranjekar P.; Prakash O.; Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Front Pharmacol  2020,10,1614","journal-title":"Front Pharmacol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s43094-023-00465-5","volume":"9","author":"Gahtori R.","year":"2023","unstructured":"Gahtori R.; Tripathi A.H.; Kumari A.; Negi N.; Paliwal A.; Tripathi P.; Joshi P.; Rai R.C.; Upadhyay S.K.; Anticancer plant-derivatives: Deciphering their oncopreventive and therapeutic potential in molecular terms. Future J Pharm Sci  2023,9(1),14","journal-title":"Future J Pharm Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/molecules26041109","volume":"26","author":"Dehelean C.A.","year":"2021","unstructured":"Dehelean C.A.; Marcovici I.; Soica C.; Mioc M.; Coricovac D.; Iurciuc S.; Cretu O.M.; Pinzaru I.; Plant-derived anticancer compounds as new perspectives in drug discovery and alternative therapy. Molecules  2021,26(4),1109","journal-title":"Molecules"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12885-016-2772-5","volume":"16","author":"Zou K.","year":"2016","unstructured":"Zou K.; Yang S.; Zheng L.; Yang C.; Xiong B.; Efficacy and safety of target combined chemotherapy in advanced gastric cancer: A meta-analysis and system review. BMC Cancer  2016,16(1),737","journal-title":"BMC Cancer"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1200\/JCO.2008.17.5844","volume":"27","author":"Di Maio M.","year":"2009","unstructured":"Di Maio M.; Chiodini P.; Georgoulias V.; Hatzidaki D.; Takeda K.; Wachters F.M.; Gebbia V.; Smit E.F.; Morabito A.; Gallo C.; Perrone F.; Gridelli C.; Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer. J Clin Oncol  2009,27(11),1836-1843","journal-title":"J Clin Oncol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.3390\/molecules28093746","volume":"28","author":"Jakobu\u0161i\u0107 Brala C.","year":"2023","unstructured":"Jakobu\u0161i\u0107 Brala C.; Karkovi\u0107 Markovi\u0107 A.; Kugi\u0107 A.; Tori\u0107 J.; Barbari\u0107 M.; Combination chemotherapy with selected polyphenols in preclinical and clinical studies-an update overview. Molecules  2023,28(9),3746","journal-title":"Molecules"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1038\/s41467-023-39122-z","volume":"14","author":"Gross S.M.","year":"2023","unstructured":"Gross S.M.; Mohammadi F.; Sanchez-Aguila C.; Zhan P.J.; Liby T.A.; Dane M.A.; Meyer A.S.; Heiser L.M.; Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects. Nat Commun  2023,14(1),3450","journal-title":"Nat Commun"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"Mokhtari R.B.","year":"2017","unstructured":"Mokhtari R.B.; Homayouni T.S.; Baluch N.; Morgatskaya E.; Kumar S.; Das B.; Yeger H.; Combination therapy in combating cancer. Oncotarget  2017,8(23),38022-38043","journal-title":"Oncotarget"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3390\/cancers13040669","volume":"13","author":"Gilad Y.","year":"2021","unstructured":"Gilad Y.; Gellerman G.; Lonard D.M.; O\u2019Malley B.W.; Drug combination in cancer treatment-from cocktails to conjugated combinations. Cancers  2021,13(4),669","journal-title":"Cancers"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/foods9040394","volume":"9","author":"Kim A.Y.","year":"2020","unstructured":"Kim A.Y.; Yun C.I.; Lee J.G.; Kim Y.J.; Determination and daily intake estimation of lignans in sesame seeds and sesame oil products in Korea. Foods  2020,9(4),394","journal-title":"Foods"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ejphar.2017.10.020","volume":"815","author":"Majdalawieh A.F.","year":"2017","unstructured":"Majdalawieh A.F.; Massri M.; Nasrallah G.K.; A comprehensive review on the anti-cancer properties and mechanisms of action of sesamin, a lignan in sesame seeds (Sesamum indicum). Eur J Pharmacol  2017,815,512-521","journal-title":"Eur J Pharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/2599689","volume":"2022","author":"Sohel M.","year":"2022","unstructured":"Sohel M.; Islam M.N.; Hossain M.A.; Sultana T.; Dutta A.; Rahman M.S.; Aktar S.; Islam K.; Al Mamun A.; Pharmacological properties to pharmacological insight of sesamin in breast cancer treatment: A literature-based review study. Int J Breast Cancer  2022,2022,1-13","journal-title":"Int J Breast Cancer"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.7150\/ijms.48955","volume":"17","author":"Kuo T.N.","year":"2020","unstructured":"Kuo T.N.; Lin C.S.; Li G.D.; Kuo C.Y.; Kao S.H.; Sesamin inhibits cervical cancer cell proliferation by promoting p53\/PTEN-mediated apoptosis. Int J Med Sci  2020,17(15),2292-2298","journal-title":"Int J Med Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"114848","DOI":"10.1016\/j.taap.2019.114848","volume":"387","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Li H.; Zhang W.; Qi W.; Lu C.; Huang H.; Yang Z.; Liu B.; Zhang L.; Sesamin suppresses NSCLC cell proliferation and induces apoptosis via Akt\/p53 pathway. Toxicol Appl Pharmacol  2020,387,114848","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/cbdd.13937","volume":"99","author":"Wen L.","year":"2022","unstructured":"Wen L.; Mao W.; Xu L.; Cai B.; Gu L.; Sesamin exerts anti-tumor activity in esophageal squamous cell carcinoma via inhibition of TRIM44 and NF-\u03baB signaling. Chem Biol Drug Des  2022,99(1),118-125","journal-title":"Chem Biol Drug Des"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.3390\/molecules24244426","volume":"24","author":"Wu M.S.","year":"2019","unstructured":"Wu M.S.; Aquino L.B.B.; Barbaza M.Y.U.; Hsieh C.L.; De Castro-Cruz K.A.; Yang L.L.; Tsai P.W.; Anti-inflammatory and anticancer properties of bioactive compounds from sesamum indicum L. - A review. Molecules  2019,24(24),4426","journal-title":"Molecules"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.urolonc.2008.07.003","volume":"28","author":"Ping S.Y.","year":"2010","unstructured":"Ping S.Y.; Hour T.C.; Lin S.R.; Yu D.S.; Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth. Urol Oncol  2010,28(2),170-179","journal-title":"Urol Oncol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1006\/bbrc.2001.5491","volume":"286","author":"Yin F.","year":"2001","unstructured":"Yin F.; Wakino S.; Liu Z.; Kim S.; Hsueh W.A.; Collins A.R.; Van Herle A.J.; Law R.E.; Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators. Biochem Biophys Res Commun  2001,286(5),916-922","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"Szklarczyk D.","year":"2023","unstructured":"Szklarczyk D.; Kirsch R.; Koutrouli M.; Nastou K.; Mehryary F.; Hachilif R.; Gable A.L.; Fang T.; Doncheva N.T.; Pyysalo S.; Bork P.; Jensen L.J.; von Mering C.; The STRING database in 2023: Protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res  2023,51(D1),D638-D646","journal-title":"Nucleic Acids Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"Kanehisa M.","year":"2000","unstructured":"Kanehisa M.; Goto S.; KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res  2000,28(1),27-30","journal-title":"Nucleic Acids Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkm882","volume":"36","author":"Kanehisa M.","year":"2007","unstructured":"Kanehisa M.; Araki M.; Goto S.; Hattori M.; Hirakawa M.; Itoh M.; Katayama T.; Kawashima S.; Okuda S.; Tokimatsu T.; Yamanishi Y.; KEGG for linking genomes to life and the environment. Nucleic Acids Res  2007,36,D480-D484","journal-title":"Nucleic Acids Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"iyad031","DOI":"10.1093\/genetics\/iyad031","volume":"224","author":"Aleksander S.A.","year":"2023","unstructured":"Aleksander S.A.; Balhoff J.; Carbon S.; Cherry J.M.; Drabkin H.J.; Ebert D.; Feuermann M.; Gaudet P.; Harris N.L.; Hill D.P.; Lee R.; Mi H.; Moxon S.; Mungall C.J.; Muruganugan A.; Mushayahama T.; Sternberg P.W.; Thomas P.D.; Van Auken K.; Ramsey J.; Siegele D.A.; Chisholm R.L.; Fey P.; Aspromonte M.C.; Nugnes M.V.; Quaglia F.; Tosatto S.; Giglio M.; Nadendla S.; Antonazzo G.; Attrill H.; dos Santos G.; Marygold S.; Strelets V.; Tabone C.J.; Thurmond J.; Zhou P.; Ahmed S.H.; Asanitthong P.; Luna Buitrago D.; Erdol M.N.; Gage M.C.; Ali Kadhum M.; Li K.Y.C.; Long M.; Michalak A.; Pesala A.; Pritazahra A.; Saverimuttu S.C.C.; Su R.; Thurlow K.E.; Lovering R.C.; Logie C.; Oliferenko S.; Blake J.; Christie K.; Corbani L.; Dolan M.E.; Drabkin H.J.; Hill D.P.; Ni L.; Sitnikov D.; Smith C.; Cuzick A.; Seager J.; Cooper L.; Elser J.; Jaiswal P.; Gupta P.; Jaiswal P.; Naithani S.; Lera-Ramirez M.; Rutherford K.; Wood V.; De Pons J.L.; Dwinell M.R.; Hayman G.T.; Kaldunski M.L.; Kwitek A.E.; Laulederkind S.J.F.; Tutaj M.A.; Vedi M.; Wang S.J.; D\u2019Eustachio P.; Aimo L.; Axelsen K.; Bridge A.; Hyka-Nouspikel N.; Morgat A.; Aleksander S.A.; Cherry J.M.; Engel S.R.; Karra K.; Miyasato S.R.; Nash R.S.; Skrzypek M.S.; Weng S.; Wong E.D.; Bakker E.; Berardini T.Z.; Reiser L.; Auchincloss A.; Axelsen K.; Argoud-Puy G.; Blatter M.C.; Boutet E.; Breuza L.; Bridge A.; Casals-Casas C.; Coudert E.; Estreicher A.; Livia Famiglietti M.; Feuermann M.; Gos A.; Gruaz-Gumowski N.; Hulo C.; Hyka-Nouspikel N.; Jungo F.; Le Mercier P.; Lieberherr D.; Masson P.; Morgat A.; Pedruzzi I.; Pourcel L.; Poux S.; Rivoire C.; Sundaram S.; Bateman A.; Bowler-Barnett E.; Bye-A-Jee H.; Denny P.; Ignatchenko A.; Ishtiaq R.; Lock A.; Lussi Y.; Magrane M.; Martin M.J.; Orchard S.; Raposo P.; Speretta E.; Tyagi N.; Warner K.; Zaru R.; Diehl A.D.; Lee R.; Chan J.; Diamantakis S.; Raciti D.; Zarowiecki M.; Fisher M.; James-Zorn C.; Ponferrada V.; Zorn A.; Ramachandran S.; Ruzicka L.; Westerfield M.; Aleksander S.A.; Balhoff J.; Carbon S.; Cherry J.M.; Drabkin H.J.; Ebert D.; Feuermann M.; Gaudet P.; Harris N.L.; Hill D.P.; Lee R.; Mi H.; Moxon S.; Mungall C.J.; Muruganugan A.; Mushayahama T.; Sternberg P.W.; Thomas P.D.; Van Auken K.; Ramsey J.; Siegele D.A.; Chisholm R.L.; Fey P.; Aspromonte M.C.; Nugnes M.V.; Quaglia F.; Tosatto S.; Giglio M.; Nadendla S.; Antonazzo G.; Attrill H.; dos Santos G.; Marygold S.; Strelets V.; Tabone C.J.; Thurmond J.; Zhou P.; Ahmed S.H.; Asanitthong P.; Luna Buitrago D.; Erdol M.N.; Gage M.C.; Ali Kadhum M.; Li K.Y.C.; Long M.; Michalak A.; Pesala A.; Pritazahra A.; Saverimuttu S.C.C.; Su R.; Thurlow K.E.; Lovering R.C.; Logie C.; Oliferenko S.; Blake J.; Christie K.; Corbani L.; Dolan M.E.; Drabkin H.J.; Hill D.P.; Ni L.; Sitnikov D.; Smith C.; Cuzick A.; Seager J.; Cooper L.; Elser J.; Jaiswal P.; Gupta P.; Jaiswal P.; Naithani S.; Lera-Ramirez M.; Rutherford K.; Wood V.; De Pons J.L.; Dwinell M.R.; Hayman G.T.; Kaldunski M.L.; Kwitek A.E.; Laulederkind S.J.F.; Tutaj M.A.; Vedi M.; Wang S-J.; D\u2019Eustachio P.; Aimo L.; Axelsen K.; Bridge A.; Hyka-Nouspikel N.; Morgat A.; Aleksander S.A.; Cherry J.M.; Engel S.R.; Karra K.; Miyasato S.R.; Nash R.S.; Skrzypek M.S.; Weng S.; Wong E.D.; Bakker E.; Berardini T.Z.; Reiser L.; Auchincloss A.; Axelsen K.; Argoud-Puy G.; Blatter M-C.; Boutet E.; Breuza L.; Bridge A.; Casals-Casas C.; Coudert E.; Estreicher A.; Livia Famiglietti M.; Feuermann M.; Gos A.; Gruaz-Gumowski N.; Hulo C.; Hyka-Nouspikel N.; Jungo F.; Le Mercier P.; Lieberherr D.; Masson P.; Morgat A.; Pedruzzi I.; Pourcel L.; Poux S.; Rivoire C.; Sundaram S.; Bateman A.; Bowler-Barnett E.; Bye-A-Jee H.; Denny P.; Ignatchenko A.; Ishtiaq R.; Lock A.; Lussi Y.; Magrane M.; Martin M.J.; Orchard S.; Raposo P.; Speretta E.; Tyagi N.; Warner K.; Zaru R.; Diehl A.D.; Lee R.; Chan J.; Diamantakis S.; Raciti D.; Zarowiecki M.; Fisher M.; James-Zorn C.; Ponferrada V.; Zorn A.; Ramachandran S.; Ruzicka L.; Westerfield M.; The gene ontology knowledgebase in 2023. Genetics  2023,224(1),iyad031","journal-title":"Genetics"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"Milacic M.","year":"2024","unstructured":"Milacic M.; Beavers D.; Conley P.; Gong C.; Gillespie M.; Griss J.; Haw R.; Jassal B.; Matthews L.; May B.; Petryszak R.; Ragueneau E.; Rothfels K.; Sevilla C.; Shamovsky V.; Stephan R.; Tiwari K.; Varusai T.; Weiser J.; Wright A.; Wu G.; Stein L.; Hermjakob H.; D\u2019Eustachio P.; The reactome pathway knowledgebase 2024. Nucleic Acids Res  2024,52(D1),D672-D678","journal-title":"Nucleic Acids Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"48876","DOI":"10.7554\/eLife.48876","volume":"8","author":"Hagenbuchner J.","year":"2019","unstructured":"Hagenbuchner J.; Obsilova V.; Kaserer T.; Kaiser N.; Rass B.; Psenakova K.; Docekal V.; Alblova M.; Kohoutova K.; Schuster D.; Aneichyk T.; Vesely J.; Obexer P.; Obsil T.; Ausserlechner M.J.; Modulating FOXO3 transcriptional activity by small, DBD-binding molecules. eLife  2019,8,48876","journal-title":"eLife"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"W324","DOI":"10.1093\/nar\/gkae300","volume":"52","author":"Bugnon M.","year":"2024","unstructured":"Bugnon M.; R\u00f6hrig U.F.; Goullieux M.; Perez M.A.S.; Daina A.; Michielin O.; Zoete V.; SwissDock 2024: Major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina. Nucleic Acids Res  2024,52(W1),W324-W332","journal-title":"Nucleic Acids Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"Daina A.","year":"2017","unstructured":"Daina A.; Michielin O.; Zoete V.; SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep  2017,7(1),42717","journal-title":"Sci Rep"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.drudis.2016.02.005","volume":"21","author":"Whitty A.","year":"2016","unstructured":"Whitty A.; Zhong M.; Viarengo L.; Beglov D.; Hall D.R.; Vajda S.; Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs. Drug Discov Today  2016,21(5),712-717","journal-title":"Drug Discov Today"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jia.2022.08.097","volume":"22","author":"Dossou S.S.K.","year":"2023","unstructured":"Dossou S.S.K.; Xu F.; Dossa K.; Zhou R.; Zhao Y.; Wang L.; Antioxidant lignans sesamin and sesamolin in sesame (Sesamum indicum L.): A comprehensive review and future prospects. J Integr Agric  2023,22(1),14-30","journal-title":"J Integr Agric"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/molecules26040883","volume":"26","author":"Andargie M.","year":"2021","unstructured":"Andargie M.; Vinas M.; Rathgeb A.; M\u00f6ller E.; Karlovsky P.; Lignans of sesame (Sesamum indicum L.): A comprehensive review. Molecules  2021,26(4),883","journal-title":"Molecules"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.foodchem.2007.05.023","volume":"105","author":"Hemalatha S.","year":"2007","unstructured":"Hemalatha S.; Ghafoorunissa ; Sesame lignans enhance the thermal stability of edible vegetable oils. Food Chem  2007,105(3),1076-1085","journal-title":"Food Chem"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.38212\/2224-6614.2241","volume":"18","author":"Chen W.L.","year":"2020","unstructured":"Chen W.L.; Lu H.C.; Huang H.Y.; Hwang G.Y.; Tzen J.T.C.; Sesame lignans significantly alleviate liver damage of rats caused by carbon tetrachloride in combination with kava. Yao Wu Shi Pin Fen Xi  2020,18(4)","journal-title":"Yao Wu Shi Pin Fen Xi"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1002\/fsn3.3407","volume":"11","author":"Hadipour E.","year":"2023","unstructured":"Hadipour E.; Emami S.A.; Tayarani-Najaran N.; Tayarani-Najaran Z.; Effects of sesame (Sesamum indicum L.) and bioactive compounds (sesamin and sesamolin) on inflammation and atherosclerosis: A review. Food Sci Nutr  2023,11(7),3729-3757","journal-title":"Food Sci Nutr"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000212735","volume":"61","author":"Ide T.","year":"2009","unstructured":"Ide T.; Nakashima Y.; Iida H.; Yasumoto S.; Katsuta M.; Lipid metabolism and nutrigenomics - impact of sesame lignans on gene expression profiles and fatty acid oxidation in rat liver. Forum Nutr  2009,61,10-24","journal-title":"Forum Nutr"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.3390\/nu14194079","volume":"14","author":"Wei P.","year":"2022","unstructured":"Wei P.; Zhao F.; Wang Z.; Wang Q.; Chai X.; Hou G.; Meng Q.; Sesame (Sesamum indicum L.): A comprehensive review of nutritional value, phytochemical composition, health benefits, development of food, and industrial applications. Nutrients  2022,14(19),4079","journal-title":"Nutrients"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.7314\/APJCP.2015.16.9.3779","volume":"16","author":"Siao A.C.","year":"2015","unstructured":"Siao A.C.; Hou C.W.; Kao Y.H.; Jeng K.C.; Effect of sesamin on apoptosis and cell cycle arrest in human breast cancer mcf-7 cells. Asian Pac J Cancer Prev  2015,16(9),3779-3783","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1248\/bpb.b13-00235","volume":"36","author":"Deng P.","year":"2013","unstructured":"Deng P.; Wang C.; Chen L.; Wang C.; Du Y.; Yan X.; Chen M.; Yang G.; He G.; Sesamin induces cell cycle arrest and apoptosis through the inhibition of signal transducer and activator of transcription 3 signalling in human hepatocellular carcinoma cell line HepG2. Biol Pharm Bull  2013,36(10),1540-1548","journal-title":"Biol Pharm Bull"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1158\/1078-0432.CCR-07-1719","volume":"14","author":"Sarkaria J.N.","year":"2008","unstructured":"Sarkaria J.N.; Kitange G.J.; James C.D.; Plummer R.; Calvert H.; Weller M.; Wick W.; Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res  2008,14(10),2900-2908","journal-title":"Clin Cancer Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/mco2.265","volume":"4","author":"Lei Z.N.","year":"2023","unstructured":"Lei Z.N.; Tian Q.; Teng Q.X.; Wurpel J.N.D.; Zeng L.; Pan Y.; Chen Z.S.; Understanding and targeting resistance mechanisms in cancer. MedComm  2023,4(3),265","journal-title":"MedComm"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s43042-020-00089-x","volume":"21","author":"Feroz W.","year":"2020","unstructured":"Feroz W.; Sheikh A.M.A.; Exploring the multiple roles of guardian of the genome: P53. Egypt J Med Hum Genet  2020,21(1),49","journal-title":"Egypt J Med Hum Genet"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3390\/cancers3010994","volume":"3","author":"Ozaki T.","year":"2011","unstructured":"Ozaki T.; Nakagawara A.; Role of p53 in cell death and human cancers. Cancers (Basel)  2011,3(1),994-1013","journal-title":"Cancers (Basel)"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"202201159","DOI":"10.1083\/jcb.202201159","volume":"221","author":"Eskandari E.","year":"2022","unstructured":"Eskandari E.; Eaves C.J.; Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J Cell Biol  2022,221(6),202201159","journal-title":"J Cell Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"a008656","DOI":"10.1101\/cshperspect.a008656","volume":"5","author":"McIlwain D.R.","year":"2013","unstructured":"McIlwain D.R.; Berger T.; Mak T.W.; Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol  2013,5(4),a008656","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"704165","DOI":"10.1155\/2008\/704165","volume":"2008","author":"Elrod H.A.","year":"2008","unstructured":"Elrod H.A.; Sun S.Y.; PPAR\u03b3 and apoptosis in cancer. PPAR Res  2008,2008(1),704165","journal-title":"PPAR Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1158\/0008-5472.CAN-09-1962","volume":"70","author":"Tsao T.","year":"2010","unstructured":"Tsao T.; Kornblau S.; Safe S.; Watt J.C.; Ruvolo V.; Chen W.; Qiu Y.; Coombes K.R.; Ju Z.; Abdelrahim M.; Schober W.; Ling X.; Kardassis D.; Meyer C.; Schimmer A.; Kantarjian H.; Andreeff M.; Konopleva M.; Role of peroxisome proliferator-activated receptor-\u03b3 and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia. Cancer Res  2010,70(12),4949-4960","journal-title":"Cancer Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.3390\/cancers12092623","volume":"12","author":"Augimeri G.","year":"2020","unstructured":"Augimeri G.; Giordano C.; Gelsomino L.; Plastina P.; Barone I.; Catalano S.; And\u00f2 S.; Bonofiglio D.; The role of ppar\u03b3 ligands in breast cancer: From basic research to clinical studies. Cancers  2020,12(9),2623","journal-title":"Cancers"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11010-020-03689-8","volume":"466","author":"S\u0142owikowski B.K.","year":"2020","unstructured":"S\u0142owikowski B.K.; Drzewiecka H.; Malesza M.; M\u0105dry I.; Sterzy\u0144ska K.; Jagodzi\u0144ski P.P.; The influence of conjugated linoleic acid on the expression of peroxisome proliferator-activated receptor-\u03b3 and selected apoptotic genes in non-small cell lung cancer. Mol Cell Biochem  2020,466(1-2),65-82","journal-title":"Mol Cell Biochem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1210\/en.2004-0686","volume":"145","author":"Hong J.","year":"2004","unstructured":"Hong J.; Samudio I.; Liu S.; Abdelrahim M.; Safe S.; Peroxisome proliferator-activated receptor \u03b3-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins. Endocrinology  2004,145(12),5774-5785","journal-title":"Endocrinology"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"57938","DOI":"10.18632\/oncotarget.18488","volume":"8","author":"Matsuda T.","year":"2017","unstructured":"Matsuda T.; Kato T.; Kiyotani K.; Tarhan Y.E.; Saloura V.; Chung S.; Ueda K.; Nakamura Y.; Park J.H.; p53-independent p21 induction by MELK inhibition. Oncotarget  2017,8(35),57938-57947","journal-title":"Oncotarget"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1158\/1541-7786.MCR-05-0121","volume":"3","author":"Aliouat-Denis C.M.","year":"2005","unstructured":"Aliouat-Denis C.M.; Dendouga N.; Van den Wyngaert I.; Goehlmann H.; Steller U.; van de Weyer I.; Van Slycken N.; Andries L.; Kass S.; Luyten W.; Janicot M.; Vialard J.E.; p53-independent regulation of p21Waf1\/Cip1 expression and senescence by Chk2. Mol Cancer Res  2005,3(11),627-634","journal-title":"Mol Cancer Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.6000\/1929-2279.2012.01.02.5","volume":"1","author":"Crispi S.","year":"2012","unstructured":"Crispi S.; The dual role played by p21 may influence the apoptotic or anti-apoptotic fate in cancer. J Cancer Res Updates  2012,1(2),189-202","journal-title":"J Cancer Res Updates"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","volume":"42","author":"Karimian A.","year":"2016","unstructured":"Karimian A.; Ahmadi Y.; Yousefi B.; Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair  2016,42,63-71","journal-title":"DNA Repair"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.12659\/MSMBR.893608","volume":"21","author":"Chen A.","year":"2015","unstructured":"Chen A.; Huang X.; Xue Z.; Cao D.; Huang K.; Chen J.; Pan Y.; Gao Y.; The role of p21 in apoptosis, proliferation, cell cycle arrest, and antioxidant activity in UVB-irradiated human HaCaT keratinocytes. Med Sci Monit Basic Res  2015,21,86-95","journal-title":"Med Sci Monit Basic Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.cellsig.2010.01.013","volume":"22","author":"Jung Y.S.","year":"2010","unstructured":"Jung Y.S.; Qian Y.; Chen X.; Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal  2010,22(7),1003-1012","journal-title":"Cell Signal"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/oncolo\/oyac138","volume":"27","author":"Wander S.A.","year":"2022","unstructured":"Wander S.A.; O\u2019Brien N.; Litchfield L.M.; O\u2019Dea D.; Morato Guimaraes C.; Slamon D.J.; Goel S.; Targeting CDK4 and 6 in cancer therapy: Emerging preclinical insights related to abemaciclib. Oncologist  2022,27(10),811-821","journal-title":"Oncologist"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ctrv.2016.03.002","volume":"45","author":"Hamilton E.","year":"2016","unstructured":"Hamilton E.; Infante J.R.; Targeting CDK4\/6 in patients with cancer. Cancer Treat Rev  2016,45,129-138","journal-title":"Cancer Treat Rev"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673401248251028114820","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/249273\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673401248251028114820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:23:14Z","timestamp":1791364994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/249273\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":61,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673401248251028114820","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-04-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}